Marker Therapeutics, Inc. (MRKR)
NCM · Common · CUSIP 57055L107
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for MRKR and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
57055L107 (prev. 876033408 )
Market Cap
Micro Cap
Previous Symbol
TPIV (changed 10/17/2018)
Previous Name
TapImmune, Inc.
Business: Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company. The Company is developing a portfolio of non-genetically modified, multi-antigen T cell therapies, which are able to recognize and kill heterogeneous tumors more effectively than conventional single-antigen CAR-T/TCR approaches.

Company Contact

CEO
Juan F. Vera
CFO
Anthony H. Kim
Headquarters
4551 Kennedy Commerce Drive, Houston, TX 77032
Phone
713-400-6400
Investor Relations
Xuan Yang · 904-862-6490 · xyang@soleburystrat.com
General Email
investor.relations@markertherapeutics.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »